Cargando…
Blood pressure-lowering medicines implemented in 12 African countries: the cross-sectional multination EIGHT study
OBJECTIVE: In Africa, the number of patients with hypertension is expected to reach 216.8 million by 2030. Large-scale data on antihypertensive medications used in Sub-Saharan Africa (SSA) are scarce. Here, we describe antihypertensive drug strategies and identify treatment factors associated with b...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8640662/ https://www.ncbi.nlm.nih.gov/pubmed/34857562 http://dx.doi.org/10.1136/bmjopen-2021-049632 |
_version_ | 1784609376686833664 |
---|---|
author | Cavagna, Pauline Takombe, Jean Laurent Damorou, Jean Marie Kouam Kouam, Charles Diop, Ibrahima Bara Ikama, Stephane Méo Kramoh, Kouadio Euloge Ali Toure, Ibrahim Balde, Dadhi Dzudie, Anastase Ferreira, Beatriz Houenassi, Martin Kane, Adama Kimbally-kaki, Suzy Gisele Kingue, Samuel Limbole, Emmanuel Mfeukeu Kuate, Liliane Mipinda, Jean Bruno N'Guetta, Roland Nhavoto, Carol Sidy Ali, Abdallahi Gaye, Bamba Tajeu, Gabriel S Macquart De Terline, Diane Perier, Marie Cécile Azizi, Michel Jouven, Xavier Antignac, Marie |
author_facet | Cavagna, Pauline Takombe, Jean Laurent Damorou, Jean Marie Kouam Kouam, Charles Diop, Ibrahima Bara Ikama, Stephane Méo Kramoh, Kouadio Euloge Ali Toure, Ibrahim Balde, Dadhi Dzudie, Anastase Ferreira, Beatriz Houenassi, Martin Kane, Adama Kimbally-kaki, Suzy Gisele Kingue, Samuel Limbole, Emmanuel Mfeukeu Kuate, Liliane Mipinda, Jean Bruno N'Guetta, Roland Nhavoto, Carol Sidy Ali, Abdallahi Gaye, Bamba Tajeu, Gabriel S Macquart De Terline, Diane Perier, Marie Cécile Azizi, Michel Jouven, Xavier Antignac, Marie |
author_sort | Cavagna, Pauline |
collection | PubMed |
description | OBJECTIVE: In Africa, the number of patients with hypertension is expected to reach 216.8 million by 2030. Large-scale data on antihypertensive medications used in Sub-Saharan Africa (SSA) are scarce. Here, we describe antihypertensive drug strategies and identify treatment factors associated with blood pressure (BP) control in 12 Sub-Saharan countries. SETTING: Outpatient consultations for hypertension in urban tertiary cardiology centres of 29 hospitals from 17 cities across 12 SSA countries between January 2014 and November 2015. PARTICIPANTS: Patients ≥18 years of age with hypertension were enrolled at any visit during outpatient consultations in the cardiology departments MAIN OUTCOME MEASURE: We collected BP levels, demographic characteristics and antihypertensive treatment use (including traditional medicine) of patients with hypertension attending outpatient visits. BP control was defined as seated office BP <140/90 mm Hg. We used logistic regression with a random effect on countries to assess factors of BP control. RESULTS: Overall, 2198 hypertensive patients were included and a total of 96.6% (n=2123) were on antihypertensive medications. Among treated patients, 653 (30.8%) patients received a monotherapy by calcium channel blocker (n=324, 49.6%), renin–angiotensin system blocker (RAS) (n=126, 19.3%) or diuretic (n=122, 18.7%). Two-drug strategies were prescribed in 927 (43.6%) patients including mainly diuretics and RAS (n=327, 42% of two-drug strategies). Prescriptions of three-drugs or more were used in 543 (25.6%) patients. Overall, among treated patients, 1630 (76.7%) had uncontrolled BP, of whom 462 (28.3%) had BP levels ≥180/110 mm Hg, mainly in those on monotherapy. After adjustment for sociodemographic factors, the use of traditional medicine was the only factor significantly associated with uncontrolled BP (OR 1.72 (1.19 to 2.49) p<0.01). CONCLUSION: Our study provided large-scale data on antihypertensive prescriptions in the African continent. Among patients declared adherent to drugs, poor BP control was significantly associated with the use of traditional medicine. |
format | Online Article Text |
id | pubmed-8640662 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-86406622021-12-15 Blood pressure-lowering medicines implemented in 12 African countries: the cross-sectional multination EIGHT study Cavagna, Pauline Takombe, Jean Laurent Damorou, Jean Marie Kouam Kouam, Charles Diop, Ibrahima Bara Ikama, Stephane Méo Kramoh, Kouadio Euloge Ali Toure, Ibrahim Balde, Dadhi Dzudie, Anastase Ferreira, Beatriz Houenassi, Martin Kane, Adama Kimbally-kaki, Suzy Gisele Kingue, Samuel Limbole, Emmanuel Mfeukeu Kuate, Liliane Mipinda, Jean Bruno N'Guetta, Roland Nhavoto, Carol Sidy Ali, Abdallahi Gaye, Bamba Tajeu, Gabriel S Macquart De Terline, Diane Perier, Marie Cécile Azizi, Michel Jouven, Xavier Antignac, Marie BMJ Open Global Health OBJECTIVE: In Africa, the number of patients with hypertension is expected to reach 216.8 million by 2030. Large-scale data on antihypertensive medications used in Sub-Saharan Africa (SSA) are scarce. Here, we describe antihypertensive drug strategies and identify treatment factors associated with blood pressure (BP) control in 12 Sub-Saharan countries. SETTING: Outpatient consultations for hypertension in urban tertiary cardiology centres of 29 hospitals from 17 cities across 12 SSA countries between January 2014 and November 2015. PARTICIPANTS: Patients ≥18 years of age with hypertension were enrolled at any visit during outpatient consultations in the cardiology departments MAIN OUTCOME MEASURE: We collected BP levels, demographic characteristics and antihypertensive treatment use (including traditional medicine) of patients with hypertension attending outpatient visits. BP control was defined as seated office BP <140/90 mm Hg. We used logistic regression with a random effect on countries to assess factors of BP control. RESULTS: Overall, 2198 hypertensive patients were included and a total of 96.6% (n=2123) were on antihypertensive medications. Among treated patients, 653 (30.8%) patients received a monotherapy by calcium channel blocker (n=324, 49.6%), renin–angiotensin system blocker (RAS) (n=126, 19.3%) or diuretic (n=122, 18.7%). Two-drug strategies were prescribed in 927 (43.6%) patients including mainly diuretics and RAS (n=327, 42% of two-drug strategies). Prescriptions of three-drugs or more were used in 543 (25.6%) patients. Overall, among treated patients, 1630 (76.7%) had uncontrolled BP, of whom 462 (28.3%) had BP levels ≥180/110 mm Hg, mainly in those on monotherapy. After adjustment for sociodemographic factors, the use of traditional medicine was the only factor significantly associated with uncontrolled BP (OR 1.72 (1.19 to 2.49) p<0.01). CONCLUSION: Our study provided large-scale data on antihypertensive prescriptions in the African continent. Among patients declared adherent to drugs, poor BP control was significantly associated with the use of traditional medicine. BMJ Publishing Group 2021-12-02 /pmc/articles/PMC8640662/ /pubmed/34857562 http://dx.doi.org/10.1136/bmjopen-2021-049632 Text en © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Global Health Cavagna, Pauline Takombe, Jean Laurent Damorou, Jean Marie Kouam Kouam, Charles Diop, Ibrahima Bara Ikama, Stephane Méo Kramoh, Kouadio Euloge Ali Toure, Ibrahim Balde, Dadhi Dzudie, Anastase Ferreira, Beatriz Houenassi, Martin Kane, Adama Kimbally-kaki, Suzy Gisele Kingue, Samuel Limbole, Emmanuel Mfeukeu Kuate, Liliane Mipinda, Jean Bruno N'Guetta, Roland Nhavoto, Carol Sidy Ali, Abdallahi Gaye, Bamba Tajeu, Gabriel S Macquart De Terline, Diane Perier, Marie Cécile Azizi, Michel Jouven, Xavier Antignac, Marie Blood pressure-lowering medicines implemented in 12 African countries: the cross-sectional multination EIGHT study |
title | Blood pressure-lowering medicines implemented in 12 African countries: the cross-sectional multination EIGHT study |
title_full | Blood pressure-lowering medicines implemented in 12 African countries: the cross-sectional multination EIGHT study |
title_fullStr | Blood pressure-lowering medicines implemented in 12 African countries: the cross-sectional multination EIGHT study |
title_full_unstemmed | Blood pressure-lowering medicines implemented in 12 African countries: the cross-sectional multination EIGHT study |
title_short | Blood pressure-lowering medicines implemented in 12 African countries: the cross-sectional multination EIGHT study |
title_sort | blood pressure-lowering medicines implemented in 12 african countries: the cross-sectional multination eight study |
topic | Global Health |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8640662/ https://www.ncbi.nlm.nih.gov/pubmed/34857562 http://dx.doi.org/10.1136/bmjopen-2021-049632 |
work_keys_str_mv | AT cavagnapauline bloodpressureloweringmedicinesimplementedin12africancountriesthecrosssectionalmultinationeightstudy AT takombejeanlaurent bloodpressureloweringmedicinesimplementedin12africancountriesthecrosssectionalmultinationeightstudy AT damoroujeanmarie bloodpressureloweringmedicinesimplementedin12africancountriesthecrosssectionalmultinationeightstudy AT kouamkouamcharles bloodpressureloweringmedicinesimplementedin12africancountriesthecrosssectionalmultinationeightstudy AT diopibrahimabara bloodpressureloweringmedicinesimplementedin12africancountriesthecrosssectionalmultinationeightstudy AT ikamastephanemeo bloodpressureloweringmedicinesimplementedin12africancountriesthecrosssectionalmultinationeightstudy AT kramohkouadioeuloge bloodpressureloweringmedicinesimplementedin12africancountriesthecrosssectionalmultinationeightstudy AT alitoureibrahim bloodpressureloweringmedicinesimplementedin12africancountriesthecrosssectionalmultinationeightstudy AT baldedadhi bloodpressureloweringmedicinesimplementedin12africancountriesthecrosssectionalmultinationeightstudy AT dzudieanastase bloodpressureloweringmedicinesimplementedin12africancountriesthecrosssectionalmultinationeightstudy AT ferreirabeatriz bloodpressureloweringmedicinesimplementedin12africancountriesthecrosssectionalmultinationeightstudy AT houenassimartin bloodpressureloweringmedicinesimplementedin12africancountriesthecrosssectionalmultinationeightstudy AT kaneadama bloodpressureloweringmedicinesimplementedin12africancountriesthecrosssectionalmultinationeightstudy AT kimballykakisuzygisele bloodpressureloweringmedicinesimplementedin12africancountriesthecrosssectionalmultinationeightstudy AT kinguesamuel bloodpressureloweringmedicinesimplementedin12africancountriesthecrosssectionalmultinationeightstudy AT limboleemmanuel bloodpressureloweringmedicinesimplementedin12africancountriesthecrosssectionalmultinationeightstudy AT mfeukeukuateliliane bloodpressureloweringmedicinesimplementedin12africancountriesthecrosssectionalmultinationeightstudy AT mipindajeanbruno bloodpressureloweringmedicinesimplementedin12africancountriesthecrosssectionalmultinationeightstudy AT nguettaroland bloodpressureloweringmedicinesimplementedin12africancountriesthecrosssectionalmultinationeightstudy AT nhavotocarol bloodpressureloweringmedicinesimplementedin12africancountriesthecrosssectionalmultinationeightstudy AT sidyaliabdallahi bloodpressureloweringmedicinesimplementedin12africancountriesthecrosssectionalmultinationeightstudy AT gayebamba bloodpressureloweringmedicinesimplementedin12africancountriesthecrosssectionalmultinationeightstudy AT tajeugabriels bloodpressureloweringmedicinesimplementedin12africancountriesthecrosssectionalmultinationeightstudy AT macquartdeterlinediane bloodpressureloweringmedicinesimplementedin12africancountriesthecrosssectionalmultinationeightstudy AT periermariececile bloodpressureloweringmedicinesimplementedin12africancountriesthecrosssectionalmultinationeightstudy AT azizimichel bloodpressureloweringmedicinesimplementedin12africancountriesthecrosssectionalmultinationeightstudy AT jouvenxavier bloodpressureloweringmedicinesimplementedin12africancountriesthecrosssectionalmultinationeightstudy AT antignacmarie bloodpressureloweringmedicinesimplementedin12africancountriesthecrosssectionalmultinationeightstudy |